title: Targeting lymphatics in inflammatory bowel disease.
authors.affiliation: Humanitas Clinical and Research Center, IBD Center, Rozzano, Italy.
authors.forename: Silvia
authors.initials: S
authors.lastname: D'Alessio
authors.affiliation: Humanitas Clinical and Research Center, IBD Center, Rozzano, Italy.
authors.forename: Carlotta
authors.initials: C
authors.lastname: Tacconi
authors.affiliation: Humanitas Clinical and Research Center, IBD Center, Rozzano, Italy.
authors.forename: Silvio
authors.initials: S
authors.lastname: Danese
mesh_terms: D003093:Colitis, Ulcerative / Q000473:pathology*; D003424:Crohn Disease / Q000473:pathology*; D041981:Gastrointestinal Tract / Q000473:pathology*; D006801:Humans; D007249:Inflammation / Q000276:immunology / Q000473:pathology; D042583:Lymphangiogenesis / Q000502:physiology*; D042601:Lymphatic Vessels / Q000166:cytology / Q000473:pathology*; D008262:Macrophage Activation / Q000276:immunology; D008264:Macrophages / Q000276:immunology; D042582:Vascular Endothelial Growth Factor C / Q000378:metabolism; D040321:Vascular Endothelial Growth Factor Receptor-3 / Q000037:antagonists & inhibitors / Q000378:metabolism
chemical_list: D042582:Vascular Endothelial Growth Factor C; C581309:FLT4 protein, human; D040321:Vascular Endothelial Growth Factor Receptor-3
keywords: IBD; VEGFC; lymphatic function; macrophages